论文信息 - Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines - 字舞流文

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines

S. Gurunathan | N. Michael | S. Sridhar | O. Launay | M. Koutsoukos | G. de Bruyn | R. Chicz | R. Forrat | L. Schuerman | F. Martinón Torres | M. Bonaparte | A. Whittington | P. Griffin | S. Savarino | J. Park | D. Brune | A. Purvis | D. Diemert | B. Fu | N. Romanyak | A. Bueso | R. Masotti | C. Rook | A. Finn | O. Haney | M. Angeles Ceregido | Marie-Hélène Grillet | S. Alvi | H. Adhikarla | L. Sher | D. M. Rivera | J. Gallais | J. Wang | M. Sánchez Ruiz | R. Canter | J. Henderson | F. Tavares-Da-Silva Sachin Deshmukh | VAT00002 booster cohorts study team